MiBio 2017 - 4th October
Downing College, Cambridge Regent St, Cambridge CB2 1DQ, UK
The MIBio conference series engages world leading experts from industry and academia in a discussion on the latest advances in biopharmaceutical formulation.
Whilst monoclonal antibodies still dominate the product pipelines, there is an increasing number of different product types in development, including antibody fragments, antibody-drug conjugates, bispecific antibodies, as well as a large variety of peptides or nucleotides, each with specific stability and drug delivery challenges. MIBio 2017 will focus on discussing these challenges as well as the latest advances in understanding molecular interactions, formulation strategies and device options to overcome them.